APSR2026-583

Yes
Late-Breaking
Submitted
Oral Presentation
AO18-003
 
 
https://storage.unitedwebnetwork.com/files/1285/1220794-46903-APSR2026-583_439935.pptx
Format: PPTX Only
 
Format: PDF Only
16. Interstitial Lung Disease
4

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Yuhei Suzuki * The University of Tokyo Hospital Department of Respiratory Medicine Tokyo Japan
Natsuki Nakagawa - The University of Tokyo Hospital Department of Respiratory Medicine Tokyo Japan
Kosuke Makita - The University of Tokyo Hospital Department of Respiratory Medicine Tokyo Japan
Hidenori Kage - The University of Tokyo Hospital Department of Respiratory Medicine Tokyo Japan
 
 
 
 
 
 
 
 
 
 
 
Presenting Author Details
Yuhei
Suzuki
doctorneet2@gmail.com
+819089428463
31-40
Japan
Original Research
A novel classification of gemcitabine-induced interstitial lung disease identified by hierarchical cluster analysis
Maximum 25 words
Abstract Content
Gemcitabine is one of the most widely used antineoplastic agents, sometimes causing interstitial lung toxicities. Gemcitabine-induced interstitial lung disease (GEM-ILD) can be a life-threatening adverse event leading to treatment discontinuation, but its clinical features remain poorly characterised. This study aimed to develop a new radiological classification of GEM-ILD that can predict clinical outcomes and guide treatment selection.
We retrospectively analysed 42 consecutive patients clinically diagnosed with GEM-ILD at our hospital. Hierarchical cluster analysis using the Jaccard distance was performed on CT findings. The clinical characteristics of each cluster were then compared across the identified clusters.
The median age of the patients was 74 years. Most cases were pancreatic cancer and showed bilateral lung abnormalities. The most frequent CT findings, in order of frequency, were ground-glass opacity (GGO), crazy-paving appearance, consolidation, thickening of interlobular septa, and pleural effusion. Because GGOs were present in most cases, hierarchical cluster analysis was performed with the other four CT findings. A four-cluster solution was adopted based on clustering metrics such as silhouette score and clinical interpretability. Cluster 1 featured predominant GGO with few accompanying CT findings. Cluster 2 was defined by consolidation in all cases, with or without GGO and few other accompanying CT abnormalities. Cluster 3 showed thickening of interlobular septa in all cases, and more than half also had crazy-paving appearance. Cluster 4 was characterised by crazy-paving appearance in all cases and frequent pleural effusion. Clinically, cluster 1 was associated with the shortest steroid treatment intensity and duration. In contrast, cluster 4 exhibited the greatest severity, including two fatal cases, and required the highest steroid dose and the longest treatment duration.
Our CT-based classification of GEM-ILD identified four distinct clusters. Notably, the crazy-paving appearance-predominant cluster was associated with the greatest severity, highlighting the potential need for more intensive treatment.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
drug-induced lung injury, gemcitabine, hierarchical cluster analysis
maximum 3 keywords and no abbreviations, separated by commas
 
296